Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12616000410459
ACTRN12616000410459
Not yet recruiting
Phase 3

Prevention of recurrent urinary tract infections in post-menopausal women using a non-antibacterial approach; a randomised, double-blinded, crossover, placebo-controlled trial of aspirin.

Prof Damon Eisen0 sites172 target enrollmentMarch 30, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Prof Damon Eisen
Enrollment
172
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 30, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Prof Damon Eisen

Eligibility Criteria

Inclusion Criteria

  • •: Post\-menopausal women who have a documented history of at least three UTIs per year.

Exclusion Criteria

  • •1\. Increased bleeding risk.
  • •2\. Hypersensitivity to aspirin.
  • •3\. Requirement for surgery to correct anatomical abnormalities predisposing to UTI.
  • •4\. Dependence on intermittent self\-catheterisation.
  • •5\. Medical illness requiring continued aspirin treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitirinary tract infections (UTIs)Urological and Genital DiseasesOther disorders of urinary system
ISRCTN76354426Magna Graecia University (Italy)60
Completed
Not Applicable
Prevention of recurrent urinary tract infections by multi-drug resistant bacteria, by intravesical administration of gentamicin.Recurrent urinary tract infection1000401810046590
NL-OMON38402eids Universitair Medisch Centrum170
Active, not recruiting
Phase 1
Preventing urinary tract infections in infants and young children with probiotic E. coli Nissle: FinNiss- trialrinary tract infectionTherapeutic area: Body processes [G] - Microbiological Phenomena [G06]
EUCTR2020-001769-35-FIOulu University Hopsital530
Terminated
Phase 4
Preventing Recurrent Urinary Tract Infections With α-D-mannoseUrinary Tract Infections
NCT03497598Kantonsspital Aarau15
Completed
Not Applicable
SPRINGStudy of Prevention of Recurrent urinary tract infections by Intravesical iNstilment of Gentamicirecurrent urinary tract infectionsmulti-drug resistant bacteriacystitisprophylaxisrecidiverende urineweginfectiesmulti resistente bacterieen
NL-OMON23211eiden University Medical Center170